GlassScriptPhysician profile
Marcus Patrick Bautista
NPI 1346873650
$4,075.18
in general payments reported to CMS, 2019-2025
22 companies · $791 in 2025
The $791 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.04 · 2022: $540 · 2023: $1,991 · 2024: $695 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,100 · Education: $340 · Consulting Fee: $37.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,099.58 |
| Education | $339.97 |
| Consulting Fee | $37.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,014.60 | 2021-2025 | Cresemba |
| Impulse Dynamics (USA) INC. | $508.36 | 2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $420.06 | 2022-2023 | Xarelto |
| United Therapeutics Corporation | $339.40 | 2023-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $275.86 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Floseal |
| Abiomed | $187.16 | 2023-2025 | Impella |
| Melinta Therapeutics, LLC | $172.92 | 2023-2024 | Rezzayo |
| Takeda Pharmaceuticals U.S.A., INC. | $159.96 | 2022-2025 | Livtencity |
| Alexion Pharmaceuticals, INC. | $134.66 | 2023 | Ultomiris |
| Amgen INC. | $124.98 | 2023 | Repatha |
| Genzyme Corporation | $116.42 | 2023 | |
| Daiichi Sankyo INC. | $115.22 | 2023 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $101.24 | 2023 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $91.81 | 2025 | Opsumit, Uptravi |
| Abbvie INC. | $84.42 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $72.90 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Adma Biomanufacturing LLC | $37.54 | 2024 | |
| Ethicon US, LLC | $36.03 | 2025 | Evarrest, Ethicon, Stratafix |
| Ani Pharmaceuticals, INC. | $27.00 | 2025 | Purified Cortrophin Gel |
| Tactile Systems Technology INC | $19.48 | 2024 | Entre Plus, Flexitouch Plus |
| Sanofi-Aventis U.S. LLC | $17.66 | 2022 | |
| Mallinckrodt Hospital Products INC. | $17.50 | 2024 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Bautista listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.